Novartis
Addressing Chronic Disease in Low-Income Countries
Pages
4
Time to read
6 mins
Publication
Language
English
Pages
4
Time to read
6 mins
Publication
Language
English
This report discusses the challenges and solutions related to chronic diseases in low-income countries, focusing on the Novartis Access program. Healthcare expert Dr. Jonathan D. Quick outlines the significant impact of noncommunicable diseases (NCDs) in these regions, where millions die annually from conditions such as cardiovascular diseases, diabetes, and respiratory illnesses. The report highlights the collaboration between Novartis and organizations like Management Sciences for Health to improve access to affordable medicines and healthcare services. It emphasizes the need for local healthcare infrastructure, trained professionals, and effective supply chain management to ensure that patients receive necessary treatments. The report also details the importance of raising awareness and education about chronic diseases, as well as the role of local governments in managing healthcare initiatives. Dr. Quick shares insights on the unique aspects of the Novartis Access program, including its targeted approach to prevalent NCDs and its commitment to empowering local healthcare systems.